HYPEREOSINOPHILIC SYNDROME
Clinical trials for HYPEREOSINOPHILIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new HYPEREOSINOPHILIC SYNDROME trials appear
Sign up with your email to follow new studies for HYPEREOSINOPHILIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental pill tested against seven rare blood diseases
Disease control CompletedThis study tested whether the drug dasatinib could help control several rare blood disorders including leukemia, myelofibrosis, and mastocytosis. Participants took dasatinib pills daily for as long as it helped control their disease. Researchers monitored blood counts and bone ma…
Matched conditions: HYPEREOSINOPHILIC SYNDROME
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug tested to tame rare blood disorder in kids
Disease control CompletedThis study tested whether a drug called mepolizumab, given as a shot under the skin, could help control a rare blood disorder called Hypereosinophilic Syndrome (HES) in children and teenagers aged 6 to 17. The main goal was to see if it could reduce the number of disease flare-up…
Matched conditions: HYPEREOSINOPHILIC SYNDROME
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Scientists hunt for clues to spot rare blood disease
Knowledge-focused CompletedThis study aimed to find new, easier-to-use markers in the blood to help doctors diagnose hypereosinophilic syndrome (HES), a rare disorder where the body makes too many of a certain type of white blood cell. Researchers analyzed blood proteins from 41 people with HES to look for…
Matched conditions: HYPEREOSINOPHILIC SYNDROME
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC